Edge Medical, a Chinese surgical robot maker backed by Singapore's Temasek Holdings, has confidentially filed for a Hong Kong initial public offering, Bloomberg News reported Friday, citing people familiar with the matter.

The Shenzhen-based company aims to raise about $150 million to $200 million as soon as this year, the report said.

GF Securities and Morgan Stanley are reportedly managing the deal, though details, including size and timing, could still change.

Edge Medical had previously sought a Hong Kong listing in 2022 but postponed the plan during a market slump, Bloomberg said.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)